India, Aug. 31 -- Clinical trials are the foundation of drug development, providing the evidence needed to determine whether a treatment is effective and safe for patients. A single clinical trial readout can add billions of dollars to a biotech company's market value or erase years of gains in a matter of hours. Yet behind headlines touting "positive data" or "statistically significant results" lies a complex set of efficacy, safety, and statistical measures that determine whether a therapy is truly a breakthrough.
Beyond terms like "met endpoint" or "statistically significant," understanding how to read clinical trial results and what trial data actually reveal about a drug's effectiveness, safety, and regulatory prospects is essential f...